The invention provides novel compounds which are capable to stimulate the proliferation
or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM).
Additionally, the invention relates to pharmaceutical compositions, medicaments
and methods for treatment of normal, degenerated and damaged NCAM presenting cells.
